Serina Therapeutics
SER
36 hedge funds and large institutions have $3.8M invested in Serina Therapeutics in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 14 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.02% less ownership
Funds ownership: 0.39% → 0.37% (-0.02%)
22% less capital invested
Capital invested by funds: $4.88M → $3.8M (-$1.08M)
25% less funds holding
Funds holding: 48 → 36 (-12)
50% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 14
86% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
+$68.9K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$50.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$14K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$13.5K |
| 5 |
SWIG
Strategic Wealth Investment Group
Louisville,
Kentucky
|
+$10.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$98.1K |
| 2 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$49K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$48K |
| 4 |
CC
Centiva Capital
New York
|
-$26K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$26K |
SER Hedge Fund Activity: Q3 2020 in Review
36 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q3 2020, worth a combined $3.8M — down 22% from $4.88M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of SER and 2 opened new positions — a net loss of 12 holders — while 14 trimmed existing stakes and 7 added.
The largest buyer was Wedbush Securities, opening a new position worth an estimated $68.9K. The largest seller was Bank of America, cutting an estimated $98.1K.
- 36 institutional investors held Serina Therapeutics (SER) as of Q3 2020, down from 48 in Q2 2020.
- Funds reported $3.8M of Serina Therapeutics stock for Q3 2020, down 22% quarter-over-quarter.
- 2 funds opened new Serina Therapeutics positions in Q3 2020 and 14 closed out, a net change of -12 holders.
- The largest Serina Therapeutics buyer in Q3 2020 was Wedbush Securities, an estimated $68.9K added.
- The largest Serina Therapeutics seller in Q3 2020 was Bank of America, an estimated $98.1K sold.
Based on aggregated 13F filings for Q3 2020.